Cargando…
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification( )
AIM: Lipoprotein(a) [Lp(a)] is a potential causal factor in the pathogenesis of aortic valve disease. However, the relationship of Lp(a) with new onset and progression of aortic valve calcium (AVC) has not been studied. The purpose of the study was to assess whether high serum levels of Lp(a) are as...
Autores principales: | Kaiser, Yannick, van der Toorn, Janine E, Singh, Sunny S, Zheng, Kang H, Kavousi, Maryam, Sijbrands, Eric J G, Stroes, Erik S G, Vernooij, Meike W, de Rijke, Yolanda B, Boekholdt, S Matthijs, Bos, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840475/ https://www.ncbi.nlm.nih.gov/pubmed/35869873 http://dx.doi.org/10.1093/eurheartj/ehac377 |
Ejemplares similares
-
Lipoprotein(a) is robustly associated with aortic valve calcium
por: Kaiser, Yannick, et al.
Publicado: (2021) -
Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply
por: Kaiser, Yannick, et al.
Publicado: (2023) -
Lipoprotein(a) is associated with a larger systemic burden of arterial calcification
por: Singh, Sunny S, et al.
Publicado: (2023) -
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
por: Kaiser, Yannick, et al.
Publicado: (2022) -
Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019)